1. The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
    Ippei Fukada et al, 2017, PLOS ONE CrossRef
  2. Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer
    Yang Yuan et al, 2023, Chinese Medical Journal CrossRef
  3. First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
    Mostafa M. Elserafi et al, 2018, Journal of the Egyptian National Cancer Institute CrossRef